Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC - 16 Year Stock Price History | AMRX

Historical daily share price chart and data for AMNEAL PHARMACEUTICALS, INC since 2009 adjusted for splits and dividends. The latest closing stock price for AMNEAL PHARMACEUTICALS, INC as of July 17, 2025 is 8.24.
  • The all-time high AMNEAL PHARMACEUTICALS, INC stock closing price was 51.31 on April 15, 2015.
  • The AMNEAL PHARMACEUTICALS, INC 52-week high stock price is 9.47, which is 14.9% above the current share price.
  • The AMNEAL PHARMACEUTICALS, INC 52-week low stock price is 6.50, which is 21.1% below the current share price.
  • The average AMNEAL PHARMACEUTICALS, INC stock price for the last 52 weeks is 8.09.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
AMNEAL PHARMACEUTICALS, INC Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 7.9710 7.7600 9.0100 6.9700 8.2400 4.04%
2024 7.0687 5.9800 9.2500 5.2400 7.9200 30.48%
2023 3.0844 2.1100 6.2100 1.2700 6.0700 205.03%
2022 3.2659 4.8500 4.8900 1.9600 1.9900 -58.46%
2021 5.3073 4.8800 7.3800 3.9500 4.7900 4.81%
2020 4.2661 4.7700 5.4600 2.4600 4.5700 -5.19%
2019 7.5244 14.1000 14.8400 2.2900 4.8200 -64.38%
2018 19.2110 17.6000 24.2700 13.0900 13.5300 -18.74%
2017 16.0902 13.5500 23.8000 8.0000 16.6500 25.66%
2016 27.8875 42.2700 42.6500 12.7500 13.2500 -69.01%
2015 43.0850 31.8000 51.3100 30.2000 42.7600 34.97%
2014 26.7322 24.8200 32.7500 22.0200 31.6800 26.01%
2013 19.9442 20.6600 25.1400 14.8000 25.1400 22.69%
2012 22.4247 20.4700 27.0200 18.6400 20.4900 1.59%
2011 21.5566 21.0800 28.7300 15.2600 20.1700 0.30%
2010 17.9160 14.0900 21.8600 13.0000 20.1100 47.76%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.589B $2.794B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.529B 28.33
Zoetis (ZTS) United States $67.467B 25.17
Takeda Pharmaceutical (TAK) Japan $46.838B 9.32
Daiichi Sankyo, - (DSNKY) Japan $44.157B 22.63
BeOne Medicines - (ONC) Cayman Islands $30.596B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.886B 0.00
Summit Therapeutics (SMMT) United States $20.995B 0.00
Merck (MKKGY) Germany $16.698B 12.23
Shionogi (SGIOY) Japan $14.207B 14.23
United Therapeutics (UTHR) United States $13.449B 11.90
Neurocrine Biosciences (NBIX) United States $13.210B 45.25
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.239B 0.00
Stevanato Group S.p.A (STVN) Italy $7.732B 47.28
Corcept Therapeutics (CORT) United States $7.725B 62.80
Madrigal Pharmaceuticals (MDGL) United States $7.659B 0.00
Grifols, S.A (GRFS) Spain $6.937B 0.00
Ionis Pharmaceuticals (IONS) United States $6.807B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.310B 0.00
Hypermarcas (HYPMY) Brazil $3.178B 20.91
Crinetics Pharmaceuticals (CRNX) United States $2.987B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.583B 9.05
NewAmsterdam Pharma (NAMS) Netherlands $2.349B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.090B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.797B 0.00
Ocular Therapeutix (OCUL) United States $1.792B 0.00
ARS Pharmaceuticals (SPRY) United States $1.755B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Guardian Pharmacy Services (GRDN) United States $1.315B 0.00
Harrow (HROW) United States $1.267B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.196B 23.92
Ardelyx (ARDX) United States $1.101B 0.00
ProKidney (PROK) United States $1.092B 0.00
Dyne Therapeutics (DYN) United States $1.061B 0.00
Enliven Therapeutics (ELVN) United States $1.053B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.030B 0.00
Akebia Therapeutics (AKBA) United States $1.024B 0.00
Collegium Pharmaceutical (COLL) United States $1.021B 5.51
Verve Therapeutics (VERV) United States $0.982B 0.00
Xeris Biopharma Holdings (XERS) United States $0.823B 0.00
KalVista Pharmaceuticals (KALV) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.751B 0.00
Zevra Therapeutics (ZVRA) United States $0.674B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.624B 0.00
USANA Health Sciences (USNA) United States $0.583B 12.68
Theravance Biopharma (TBPH) United States $0.583B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Organogenesis (ORGO) United States $0.566B 0.00
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Bioventus (BVS) United States $0.545B 13.83
Siga Technologies (SIGA) United States $0.484B 10.12
Tourmaline Bio (TRML) United States $0.476B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Savara (SVRA) United States $0.399B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.345B 9.31
Altimmune (ALT) United States $0.339B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.332B 0.00
Aldeyra Therapeutics (ALDX) United States $0.309B 0.00
Heron Therapeutics (HRTX) United States $0.308B 0.00
AleAnna (ANNA) United States $0.305B 0.00
Nektar Therapeutics (NKTR) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 25.78
Nanobiotix S.A (NBTX) France $0.246B 0.00
OmniAb (OABI) United States $0.242B 0.00
Esperion Therapeutics (ESPR) United States $0.222B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.197B 0.00
China SXT Pharmaceuticals (SXTC) China $0.194B 0.00
Galectin Therapeutics (GALT) United States $0.180B 0.00
Profound Medical (PROF) Canada $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.171B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Avita Medical (RCEL) United States $0.141B 0.00
Liminatus Pharma (LIMN) United States $0.140B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Korro Bio (KRRO) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.120B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.73
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Metagenomi (MGX) United States $0.079B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.078B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Jupiter Neurosciences (JUNS) United States $0.072B 0.00
Surrozen (SRZN) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Klotho Neurosciences (KLTO) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 43.11
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Plus Therapeutics (PSTV) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 2.57
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.12
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00